ARTHROJET XT— 510(k) K041233

Name: FDA 510(k) clearance K041233
Creator: U.S. Food and Drug Administration
Published: 2004-07-28

Substantially Equivalent

Hydrocision, Inc.

FDA 510(k) clearance K041233 for ARTHROJET XT, Substantially Equivalent on 2004-07-28. Applicant: Hydrocision, Inc.. Device class: 2.

Clearance details

Applicant: Hydrocision, Inc.
Product code: Code HRX
Device class: Class 2
Regulation: 21 CFR 888.1100
Advisory panel: Orthopedic
Date received: 2004-05-10
Decision date: 2004-07-28
Decision: Substantially Equivalent
Clearance type: Special
Location: Hopkonton, MA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code HRX

view all

K260203 — Fule Vertebroplasty Balloon Catheter2026-08-28
K254103 — HOPKINS Telescopes for Arthroscopy2026-08-26
K252790 — Digital ClarusScope System and Digital NeuroPEN System2026-05-26
K253523 — Freedom DS Decompression System2026-04-16
K252546 — VantageTM Lumbar Decompression Kit2026-03-12

More clearances from Hydrocision, Inc.

view all

K241990 — SpineSite Endoscope System2025-07-30
K200729 — HydroCision SpineJet System2020-04-16
K190804 — HydroCision TenJet Device2019-06-05
K032529 — HYDROCISION ARTHROJET SYSTEM WITH CAUTERY, TURBOBURR AND CURETTE, MODELS 51300, 513102003-09-16
K021813 — HYDROCISION GENERAL SURGERY FLUIDJET SYSTEM2003-05-09

Adverse events under product code HRX

product code HRX

Injury: 623
Malfunction: 11,257
Total: 11,880

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.